Breast Hypertrophy Induced by Ombitasvir/Paritaprevir/Ritonavir and Ribavirina-Reference-Cited by-同舟云学术

Breast Hypertrophy Induced by Ombitasvir/Paritaprevir/Ritonavir and Ribavirina

Published:2016-08-04 Issue:6 Volume:22 Page:708-709
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast J

Author:

Gentili Marta¹,Magni Carlo²,Carnovale Carla¹,Bolis Matteo²,Landonio Simona²,Niero Fosca²,Antoniazzi Stefania¹³,Clementi Emilio⁴⁵,Radice Sonia¹

Affiliation:

1. Unit of Clinical Pharmacology; Department of Biomedical and Clinical Sciences; “Luigi Sacco” University Hospital; Università di Milano; Milan Italy

2. Units of Infectious Diseases; “Luigi Sacco” University Hospital; Università di Milano; Milan Italy

3. Scientific Direction; IRCCS Foundation Ca’ Granda Ospedale Maggiore Policlinico; Milan Italy

4. Scientific Institute; IRCCS E. Medea; Lecco Italy

5. Unit of Clinical Pharmacology; Department of Biomedical and Clinical Sciences; Consiglio Nazionale delle Ricerche; Institute of Neuroscience; University Hospital “Luigi Sacco”; Università di Milano; Milan Italy

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tbj.12656/fullpdf

Reference7 articles.

1. http://www.who.int

2. http://www.agenziafarmaco.gov.it

3. http://ec.europa.eu/health/documents/community-20register/2015/20150115130406/anx_130406_it.pdf

4. Norvir (ritonavir capsules) package insert Aprilia AbbVie 2015

5. Hypertrophy of the breast in a patient treated with indinavir;Herry;Clin Infect Dis,1997

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Safety Outcomes in Chronic Hepatitis C Patients using Interferon-free Treatment: A Systematic Review of Case Reports;Current Drug Therapy;2019-10-23

2. Developmental disorders and malformations of the breast;Seminars in Diagnostic Pathology;2019-01

3. Antivirals;Reactions Weekly;2017-01